IFITM1 and colorectal cancer: As IFITM1 has been shown to be increased in cervical, esophageal, ovarian, brain and colon cancers [27–31], we analyzed the expression of IFITM1 in multiple patient-derived colorectal cancer cell lines by immunoblot.